Mr Chew Sutat, SGX head of equities and fixed income, told an exchange event yesterday: “The US, we do acknowledge, is a great market for tech today. There are companies like Snap that have no profits that can actually raise quite good money.
“But in Asia today, there isn’t a single market that is a pre-eminent market for technology.” He was speaking to the media on the sidelines of the SGX-CIMB Disruptors’ Day yesterday.
Earlier this week, investors heard that Singapore-based Sea, formerly Garena and reportedly South-east Asia’s most valuable start-up, had filed for an initial public offering in the United States.
Local biotech firm Aslan Pharmaceuticals is planning to debut on the Taipei Exchange next month.
In recent years, a number of smaller local tech firms have also opted to launch their IPOs in Australia. – THE STRAITS TIMES